Clinical Transplantation

Article	Citations
	52
Does dialysis modality or duration influence outcomes in simultaneous pancreas‐kidney transplant recipients? Single center experience and review of the literature	45
Association of body mass index with post‐liver transplant outcomes	38
Persisting dental foci increase the risk for bacterial infections before and after liver transplant	36
Beyond Borders: International Immunosuppression Practices in Pediatric Lung Transplantation	36
Impact of kidney transplant on post‐operative morbidity and mortality in patients with pre‐operative cardiac dysfunction	33
Mandating COVID‐19 immunization for living organ donors	31
Impact of Heart Failure Etiology on Waitlist Mortality in Heart Transplant Candidates Supported With Extracorporeal Membrane Oxygenation	31
Perioperative Bleeding Risk in Lung Transplantation After Previous Cardiothoracic Surgery	30
Geographic Variation Exists in Heart Transplantation for Status One and Two Patients After the 2018 Heart Allocation Policy Change	30
Advancement of Heart Transplantation in Thai Recipients: Survival Trends and Pharmacogenetic Insights	24
Toward continuous improvement of Scientific Registry of Transplant Recipients performance reporting: Advances following 2012 consensus conference and future consensus building for 2022 consensus confe	24
External Validation of a Limited Sampling Strategy for the Estimation of Mycophenolic Acid Exposure Between Different Assay Methods: PETINIA and HPLC Methods	24
Issue Information	23
Contemporary Immunosuppression Management and 1‐Year Outcomes in Dual Organ Heart Transplantation	22
Issue Information	21
Transplantation in Iran	21
Feasibility of providing web‐based education to patients prior to kidney transplant evaluation	21
Hyperfibrinolysis Detection During Liver Transplantation Using Viscoelastometry	20
Factors associated with telemedicine utilization among post‐transplant patients at a university kidney and pancreas transplant center	20
Diagnosis of Cutaneous Acute Graft‑Versus‑Host Disease Through Circulating Plasma miR‐638, miR‐6511b‐5p, miR‐3613‐5p, miR‐455‐3p, miR‐5787, and miR‐548a‐3p as Prospective Noninvasive Biomarkers Follow	19
Sociodemographic disparities in sodium‐glucose cotransporter‐2 inhibitor use among US kidney transplant recipients: An observational study of real‐world pharmacy records	19
Increased intrarenal post‐glomerular blood flow is a key condition for the development of calcineurin inhibitor‐induced renal tubular acidosis in kidney transplant recipients	19
Ultrasound Utilization in Hospitalized Kidney Transplant Recipients: Useful or Overused?	19
Cellular Cancer Immunotherapy in the Liver Transplant Population for HCC: An Attractive Therapeutic Option for the Next Decade	18

Advances and innovations in living donor liver transplant techniques, matching and surgical training: Meeting report from the living donor liver transplant consensus conference	18
A 12‐Year Analysis of Equity and Efficiency in Living Kidney Donation at a Rural American Center	18
Organ Donor Potential After Extracorporeal Cardiopulmonary Resuscitation for Out‐of‐Hospital Cardiac Arrest: A Post‐Hoc Analysis of a Randomized Controlled Trial	17
Financial impact of donation after circulatory death heart transplantation: A single‐center analysis	17
Preliminary feasibility of animated video education designed to empower patients’ referral to kidney transplantation	17
Efficacy, Tolerability, and Safety of Glucagon‐Like Peptide 1 Receptor Agonists (GLP1‐RA) in Kidney Transplant Recipients With Diabetes	17
Impact of Share 35 liver transplantation allocation in Australia and New Zealand	16
Restriction of interleukin‐6 alters endothelial cell immunogenicity in an allogenic environment	16
The optimal immunosuppression management to prevent early rejection after liver transplantation: A systematic review of the literature and expert panel recommendations	16
Decreasing the Risk of Early Sub‐Therapeutic Tacrolimus Troughs on Short‐Term Outcomes in Low‐Moderate Risk Kidney Transplant Recipients Receiving Rabbit Anti‐Thymocyte Globulin Induction	16
The impact of the distance between patient residency and heart transplant center on outcomes after heart transplantation	16
Deep vein thrombosis and pulmonary embolism after heart transplantation	16
Pulse Wave Velocity in Pediatric Heart Transplant Recipients–A Marker of Vascular Health	16
Initial Efforts to Stratify Patients and Donors Utilizing Normothermic Machine Preservation of Livers for Transplant	16
Sleep and Respiratory Parameters After Lung Transplantation in Adult Patients With Cystic Fibrosis	15
Rabbit antithymocyte globulin dose and early subclinical and clinical rejections in kidney transplantation	15
Ultrasound‐Guided Modified Thoracoabdominal Nerve Block Through Perichondrial Approach for Postoperative Analgesia Management in Living Liver Donors: A Randomized, Prospective, Controlled Study	15
Perioperative Timing Impacts Renal Graft Outcomes in Simultaneous Heart‐Kidney Transplantation	15
Coronavirus disease 2019 vaccine in pediatric post‐kidney transplantation	15
Recurrence of Primary Sclerosing Cholangitis and De Novo Cholangiocarcinoma After Liver Transplantation: Results From the Brazilian Cholestasis Consortium	15
Advances and Challenges of Thrombolytic Therapy for Donation After Circulatory Death Organs	15
Size‐mismatched transplantation from large donors to small recipients is associated with pancreas graft thrombosis: A retrospective national observational study	15
Issue Information	15
	15
Covid‐19 positive donor utilization for heart transplantation: The new frontier for donor pool expansion	14
Donor‐Derived Cell‐Free DNA for Diagnosing Subclinical Rejection: A Pilot Multicenter Study in Japanese Living‐Donor Kidney Transplantation	14
Comparison of outcomes in vaccinated versus unvaccinated COVID‐19 kidney transplant recipients, a single center retrospective study—Is the taboo justified?	14
Extracorporeal Photopheresis in the Treatment of Cardiac Allograft Rejection in the Modern Era: A Single‐Center Experience	14
Deep Learning‐Based MRI Volumetry for Living Kidney Donor Assessment: A New Tool for Predicting Post‐Donation Renal Function	13
Seasonal Patterns of Living Kidney Donation in the United States From 1995 to 2019	13
Postoperative Fluid Accumulation is Associated With Underestimation of AKI Severity in Lung Transplant Recipients	13
Perfusion and oxygenation in allografts with transplant renal artery stenosis: Evaluation with functional magnetic resonance imaging	13
Intraoperative hypotension and the risk of acute kidney injury following liver transplantation	13
Association of Donor Vascular Endothelial Growth Factor Gene Polymorphism With Acute Renal Allograft Rejection	13
Economic Impact of Dementia After Kidney Transplantation: A Matched Cohort Analysis	13
Public Acceptance of Living Donor Liver Transplant for Colorectal Liver Metastases: A Web‐Based Survey	13
Pretransplant Diabetes Mellitus and Obesity in Recipients Is Associated With Reduced Survival Following Donation After Circulatory Death Heart Transplantation	13
Transplantation Related Mortality Did Not Show Significant Differences in Patients Aged Above 55 Years With Hematological Malignancies Receiving Allogeneic Hematopoietic Stem Cell Transplantation in a	13
Epidemiology and outcomes associated with enterococcal blood stream infection among liver and kidney transplant recipients	13
A single center Israeli experience in pregnancy post lung transplantation: Feasibility of successful two or more full‐term pregnancies in individual lung transplant recipients	13
Alternative‐Donor Transplants in Adults ≤ 55 Years Old With Haematological Cancers: Young Versus Older Related HLA‐Haplotype‐Mismatched Donor Versus Unrelated Umbilical Cord Blood	12
Surgical complications and technical failure of simultaneous pancreas‐kidney transplantation: A 22‐year experience from a single center	12
Impact of Sodium‐Glucose Cotransporter‐2 Inhibitors on Proteinuria in Kidney Transplant Recipients	12
High grade urothelial carcinoma in kidney transplant patients with a history of BK viremia – Just a coincidence?	12
The changing landscape of pediatric lung transplantation	12
Is it safe to expand the indications for split liver transplantation in adults? A single‐center analysis of 155 in‐situ splits	12
Early Conversion to Everolimus Within 180 Days of Living Donor Liver Transplantation	12
Attitudes and Perceptions of Infectious Disease Providers Toward Transplantation From Living Donors With HIV to Recipients With HIV	12
Worldwide organ allocation systems for pediatric lung transplantation	12
Issue Information	12

Increased Mortality in Kidney Transplant Recipients During the Delta/Omicron Era of the COVID‐19 Pandemic Despite Widespread Vaccination	12
Surgical complications after living and deceased donor liver transplant: The NSQIP transplant experience	12
Five Decades of Pancreas Transplantation at the University Hospital of Zurich—A Story of Continuous Improvement and Success	12
The effect of intensity of conditioning regimen on the outcome of HSCT in children with sickle cell disease	12
Outcomes following heart or bilateral‐lung transplantation from donors who died of drug toxicity in British Columbia, Canada	12
Effectiveness and safety of glucagon‐like peptide‐1 receptor agonist in a cohort of kidney transplant recipients	12
Liver Transplant Fast‐Track With an Emphasis on Reduced Delirium: A Multidisciplinary Approach to Reducing Length of Stay	11
Issue Information	11
Does Weekend Discharge Affect Readmission and Survival in Liver Transplant Patients? Insights From a Cohort Study	11
Diagnosis and predicted outcomes of patients with cystic fibrosis related liver disease considered for lung transplantation	11
Effectiveness and safety of once‐daily tacrolimus formulations in de novo liver transplant recipients: The PRETHI study	11
	11
Immune Checkpoint Inhibitor Use in Kidney Transplant Patients: A National Case Series From Ireland	11
A survey of intensive care unit models in cardiothoracic transplantation at high‐volume centers	11
Hemodynamic failure and graft dysfunction after lung transplant: A possible clinical continuum with immediate and long‐term consequences	11
Textbook surgical outcome in lung transplantation: Analysis of a US national registry	11
Efficacy and Safety of Perioperative Angiotensin II Versus Phenylephrine as a First‐Line Continuous Infusion Vasopressor in Kidney Transplant Recipients	11
Comparing Mid‐Term Outcomes of Donation After Brain Death and Donation After Circulatory Death Orthotopic Heart Transplant Recipients–A Single‐Center Retrospective UK Study	10
Long term tolerability and clinical outcomes associated with tocilizumab in the treatment of refractory antibody mediated rejection (AMR) in pediatric renal transplant recipients	10
Post‐kidney transplant body mass index trajectories are associated with graft loss and mortality	10
Perioperative fluid management and outcomes in adult deceased donor liver transplantation – A systematic review of the literature and expert panel recommendations	10
Impact of induction therapy on cytomegalovirus infection and post‐transplant outcomes in pediatric heart transplant recipients receiving routine antiviral prophylaxis	10
Efficacy and safety of total lymphoid irradiation in different chronic lung allograft dysfunction phenotypes	10
Sodium‐glucose co‐transporter 2 inhibitors & glucagon‐like peptide‐1 receptor agonists, efficacy & safety in diabetic kidney transplant recipients	10
A report of a prospective randomized trial of extended‐release tacrolimus versus immediate release tacrolimus after liver transplantation with anti‐thymocyte induction in a steroid free protocol	10
Impact of OPTN policy 3.7D providing waiting time modification for candidates affected by race‐inclusive eGFR calculations: Early results from a single center	10
Early reversal of the lymphocyte‐to‐monocyte ratio after allogeneic‐hematopoietic stem cell transplantation is associated with reduced relapse and improved prognosis	10
Skin Closure Technique Matters: Fewer Wound Infections After Kidney Transplant in Patients With Class 2 Obesity Using Subcuticular Sutures	10
	10
Effects of angiotensin II in the management of perioperative hypotension in kidney transplant recipients	10
Managing the significant drug‐drug interaction between isavuconazole and tacrolimus in solid organ transplant recipients	9
Safety of glucose‐6 phosphate dehydrogenase deficient donors in living right lobe liver donation	9
In Memoriam—Professor Sir Peter Morris	9
A geographic information system dashboard for heart transplantation	9
Impact of GLP‐1 and GLP‐1/GIP Receptor Agonist Weight Loss Post‐Lung Transplant on Lung Allograft Function	9
The utility of inpatient rehabilitation in heart transplantation: A review	9
COVID‐19 infection in patients with history of pediatric heart transplant in Germany, Austria, and Switzerland	9
Quality of Life in Patients 20–31 Years After Heart Transplantation	9
Lung transplantation in the septuagenarian can be successfully performed though long‐term results impacted by diseases of aging	9
Heart transplant in a Sars‐CoV‐2 positive recipient: Management protocol of the world's first case	9
Assessing the influence of graft loss on 4‐year patient survival after simultaneous pancreas‐kidney transplantation: Kaplan–Meier versus Competing Risk Analysis model	9
How the websites of high‐volume US centers address the risks of living kidney donation	9
Multi‐phasic eGFR trajectory during follow up and long‐term graft failure after kidney transplantation	9
Successful Kidney Transplantation Despite Therapeutic Anticoagulation—Effective Apixaban Elimination by Hemoadsorption	9
Higher number of tacrolimus dose adjustments in kidney transplant recipients who are extensive and intermediate CYP3A5 metabolizers	9
Regional Disparities in Kidney Transplant Allocation in Brazil: A Retrospective Cohort Study	9
Outcomes of Patients With Severe and Very Severe Hepatopulmonary Syndrome After Liver Transplantation at a High‐Volume Transplant Center: A Case Series Hepatopulmonary Syndrome Post‐Transplant	9
Galectin‐3 as an independent prognostic factor after heart transplantation	9
Effects of Nighttime Procurement and Transplantation on Outcomes Following Heart Transplantation	9
Donor rhabdomyolysis, acute kidney injury, and kidney transplant outcomes	9
Exploring Anesthesiology Management of Living Donor Liver Transplantation: Survey From the Society for the Advancement of Transplant Anesthesia and the Korean Society for Transplantation Anesthesiolog	9
Emerging Therapeutic Strategies for Renal Ischemia‐Reperfusion Injury in Kidney Transplantation: Progress and Challenges—A Systematic Review	9
Progression of Intraductal Papillary Mucinous Neoplasms of the Pancreas After Liver Transplantation	9
Outcomes after lung resection in renal transplant patients with pulmonary mucormycosis	9
Successful liver transplantation from deceased donors with active COVID‐19 infections with undetectable SARS‐CoV‐2 in donor liver and aorta	9
Understanding Racial Disparities in Lung Transplant Outcomes: A Comparative Study of White and Hispanic Patients	9
CXCL9 and CXCL10 as biomarkers of kidney graft inflammation across multiple conditions	8
Can we HALT obesity following lung transplant? A Dietitian‐ and Physiotherapy‐directed pilot intervention	8
Hepatitis C and heart transplantation: An update	8
Association of physical activity with fractures in kidney transplant recipients: A Korean nationwide cohort study	8
Heart transplantation in the era of corona virus disease 2019: Impact of the pandemic on donors, recipients and outcome	8
The liver frailty index is a predictor of healthcare utilization after liver transplantation in older adults	8
Clinical and Economic Impact of CMV Infection in Allogeneic Hematopoietic Stem Cell Transplantation: Perspectives from a Middle‐Income Nation	8
Multiple abnormal peripheral blood gene expression assay results are correlated with subsequent graft loss after kidney transplantation	8
Outcomes and Tolerability of Early Mammalian Target of Rapamycin Inhibitor Initiation for Renal Sparing in Heart Transplant Recipients	8
Does lung procurement and exposure to Perfadex impact heart transplantation outcomes	8
Do outcomes for heart transplantation differ based on donor and recipient race?	8
Organ transplant and Covid‐19 vaccination: Considering the ethics of denying transplant to unvaccinated patients	8
Project Donor: A National Intervention to Improve the Health of Potential Living Donors	8
What is the optimal management of thromboprophylaxis after liver transplantation regarding prevention of bleeding, hepatic artery, or portal vein thrombosis? A systematic review of the literature and	8
Dual‐Energy X‐Ray Absorptiometry‐Derived Advanced Hip Analysis and the Trabecular Bone Score Are Associated With the Diagnosis of Fracture Following Kidney and Simultaneous Pancreas‐Kidney Transplanta	8
Prolonged cold ischemia and kidney donation after cardiac death	8
Anticoagulation and safety of renal transplant biopsy	8
Stratifying Post‐Transplant Diabetes: Prognostic Impact of Insulin Dependence and Treatment Duration	8
Impact of donation after circulatory death heart transplantation on waitlist outcomes and transplantation activity	8
Posterior reversible encephalopathy syndrome after lung transplantation: Risk factors and management	8
Lung transplant airway complications treated with biodegradable airway stents: The Dutch multi‐center experience	8
Lessons Learned From Extracorporeal Life Support Practice and Outcomes During the COVID‐19 Pandemic	8
Tixagevimab/cilgavimab for the prevention of COVID‐19 in solid organ transplant recipients	8
Cover Image, Volume 37, Issue 7	8

Organ Offer Review Cards: Improving Transparency on the Kidney Transplant Waitlist	8
Recipient Outcomes After Utilization of Kidneys From Deceased Donors With Diagnosed Glioblastoma Multiforme	8
Cystic fibrosis survival outcomes following second lung transplant: The north American experience	8
Impact of Academic Background on Early Hospital Readmission and Graft Survival After Liver Transplantation: A Single‐Center Experience in Ohio	8
Enhanced Artificial Intelligence Methods for Liver Steatosis Assessment Using Machine Learning and Color Image Processing: Liver Color Project	7
Factors associated with early postoperative exercise tolerance after living‐donor liver transplantation	7
Long‐term outcomes after heart transplantation using ex vivo allograft perfusion in standard risk donors: A single‐center experience	7
Real world experience with Maribavir for the treatment of cytomegalovirus in solid organ transplant recipients	7
	7
Cover Image, Volume 38, Issue 8	7
	7
Absence of hemoglobin increase is associated with reduced graft survival after kidney transplantation	7
De Novo Letermovir After Cytomegalovirus Seropositive Kidney Transplant Improves Toxicity and Mycophenolate Tolerance Over the Current Standard of Care	7
Early post‐transplant leukopenia in heart transplant recipients and its impact on outcomes	7
Review–Long‐Term Care of Kidney Transplant Patients	7
Factors influencing organ donation in Fujian's Organ Procurement Organization: A retrospective study	7
Increasing nonalcoholic steatohepatitis overlap in liver transplant recipients: Additive risk for de novo malignancy	7
Assessment of Posttransplant Bacteremia Caused by Extended‐Spectrum Beta‐Lactamase–Producing Gram‐Negative Bacteria Among Kidney Transplant Recipients	7
Issue Information	7
High rate of adenovirus detection in gastrointestinal biopsies of symptomatic stem cell transplant recipients	7
The heart transplant allocation change attenuates but does not eliminate blood group O waitlist outcome disadvantage	7
A2/A2B to B kidney transplantation outcomes: A single center 7‐year experience	7
Hepatitis B Boosters Using a Different Product vs. the Same Product for Kidney Transplant Recipients: A Retrospective Study With Bayesian Inference	7
“You don't know what you don't know”: A qualitative study of informational needs of patients, family members, and living donors to inform transplant system metrics	7
Cardio‐Renal‐Metabolic Outcomes Associated With the Use of GLP‐1 Receptor Agonists After Heart Transplantation	7
Effects of Perioperative Rehabilitation on Physical Function in Kidney Transplant Recipients	7
Pre‐ and Post‐Kidney Transplant Abdominal Computed Tomography‐Based Muscle Measurements and Post‐KT Outcomes	7
	7
Impact of prior COVID‐19 infection on allogeneic hematopoietic stem cell transplantation outcomes	7
Mismatched perfusion defects on routine ventilation‐perfusion scans after lung transplantation	7
Utility of Quadratus Lumborum Blocks in Patients Who Undergo Liver Transplant: A Single‐Center Retrospective Study	7
Interaction between ischemic time and donor age under the new donor heart allocation system: Effect on post‐transplant survival	7
mTORi‐based immunosuppression reduces HCC recurrence at the expense of increased adverse side effects: A systematic review and meta‐analysis	7
Association between artificial nutrition in brain dead donors and early allograft function in liver transplant recipients: an observational study	7
Social network interventions to reduce race disparities in living kidney donation: Design and rationale of the friends and family of kidney transplant patients study (FFKTPS)	7
Association of HLA Mismatch With Adverse Cardiovascular Events Following Lung Transplantation: A Single‐Center Study	7
A viewpoint describing the American Society of Transplantation rationale to conduct a comprehensive patient survey assessing unmet immunosuppressive therapy needs	7
Impact of Ex Vivo Lung Perfusion on Inpatient Cost: A Propensity Score‐Matched Analysis of the US Nationwide Healthcare Cost and Utilization Project Database	7
Hepatitis C viremic lung transplantation to aviremic recipients: Comprehensive outcomes and post‐transplant viremia	7
Eculizumab as Salvage Treatment for Thrombotic Microangiopathy After Lung Transplantation	7
Independent Risk Factors and Economic Burden Associated With Delayed Extubation Following Pediatric Liver Transplantation	7
Hepatitis B Virus NAT Positive Donors in Non‐Hepatic Organ Transplant: Quantifying Viral Loads to Optimize Recipient Risk Stratification and Management in the Prevention of Donor‐Derived Infection	7
Incidence and Risk Factors for Stroke After Combined Heart‐Kidney and Heart‐Liver Transplantation	6
Lung transplantation in primary pulmonary arterial hypertension and pulmonary venous hypertension	6
Type A Aortic Dissection Following Abdominal Solid Organ Transplantation: Population‐Level Outcomes in the United States	6
Lack of Association Between Donor‐Derived Cell‐Free DNA and Cardiac Allograft Vasculopathy	6
	6
Phenytoin to expedite sirolimus and tacrolimus elimination	6
Lessons Learned in Research and Development With Porcine Livers and the Clinical Translation—Beating the Organ Clock With Normothermic Machine Perfusion	6
Basiliximab induction versus no induction in adult heart transplantation	6
Early post‐operative lactate increase following kidney transplant is associated with delayed graft function: A retrospective cohort study	6
	6
Benefits of both physical assessment and electronic health record review to assess frailty prior to heart transplant	6
Hepatitis B Vaccine Compliance, Serologic Response, and Durability in Adult Thoracic Organ Transplant Recipients	6
Prior SARS‐CoV‐2 infection may not alter the clinical course of COVID‐19 in lung transplant recipients: A single‐center experience	6
Risk and Reward: Nationwide Analysis of Cardiac Transplant Center Variation in Organ Travel Distance and the Effects on Outcomes	6
Issue Information	6
Evaluation of Single Versus Two‐Dose Basiliximab Induction Therapy in Live‐Donor Liver Transplant	6
Programmed cell death ligand 1 expression associated with subtypes of post‐transplant lymphoproliferative disorder among pediatric kidney transplant recipients	6
Does bortezomib influence pre‐transplant desensitization therapy or benefit post‐heart transplant outcomes for highly sensitized patients?	6
Variation Across Organ Procurement Organizations in Deceased‐Donor Kidney Offer Notification Practices	6
When is the optimal time to discharge patients after liver transplantation with respect to short‐term outcomes? A systematic review of the literature and expert panel recommendations	6
Arterialization of the Portal Vein: A Potentially Graft‐Saving Strategy to Optimize Veno‐Arterial Inflow in Liver Transplantation	6
Two decades of stem cell transplantation in patients with Fanconi anemia: Analysis of factors affecting transplant outcomes	6
Disparities in telemedicine utilization among kidney transplant patients during the COVID‐19 pandemic: Barriers and opportunities	6
Donor heart dysfunction and graft survival in liver and kidney transplants—A register‐based study from Sweden	6
Utilization and discard of organs from donors with COVID‐19 in the United States	6
Role of time from transplantation to biopsy in histologic ABMR: A single center report	6
Anticoagulation and Antiplatelet Regimen in Cardiac Transplant. Clinical Characteristics, Outcomes, and Blood Product Transfusion	6
Blood salvage and autotransfusion during orthotopic liver transplantation for hepatocellular carcinoma: A systematic review and meta‐analysis	6
Immune outcomes of lung transplant recipients with different cytochrome P450 3A5 phenotypes after discontinuation of voriconazole antifungal prophylaxis	6
Management of Cytomegalovirus Infection in Allogeneic Hematopoietic Stem Cell and in Solid Organ Transplantation: Updated Recommendations by the GITMO, SITO, SIMIT, and AMCLI Italian Societies	6
Factors associated with a positive phosphatidylethanol test during liver transplantation evaluation	6
Critical interactions between race and the highly granular area deprivation index in liver transplant evaluation	6
Risk Factors and Outcomes of Invasive Candida Infections in Heart Transplant Recipients: A Case‐Control Study	6
Anti‐Thymocyte Globulin as a Therapy for Chronic Lung Allograft Dysfunction: A Single‐Center Experience	6
Impact of Restrictive Cardiac Allograft Physiology on Heart Re‐Transplantation Outcomes	6
Examining the transplant case composition of early‐career transplant surgeons	6
Poor utilization of deceased donor pancreata in the United States: Time for action	6
Veno‐arterial ECMO ventricular assistance as a direct bridge to heart transplant: A single center experience in a low‐middle income country	6
Thoracic transplantation during the COVID‐19 pandemic	6
Generic Versus Brand‐Name Immunosuppression Following Heart Transplant: An Analysis of the UNOS Database	6
Ventilatory efficiency measured during sub‐maximal cardiopulmonary exercise testing predicts postoperative outcomes following heart transplantation	5
Toward optimization of cyclosporine concentration target to prevent acute graft‐versus‐host disease following myeloablative allogeneic stem cell transplant	5
In memoriam—Dr. Anthony Monaco	5
Comprehensive review: Frailty in pancreas transplant candidates and recipients	5
Allorgafting for Aplastic Anemia on a Background of HELLP Syndrome in Identical Twins	5
Intravenous Immunoglobulins Alone for the Desensitization of Lung Transplant Recipients with Preformed Donor Specific Antibodies and Negative Flow Cytometry Crossmatch	5
Kidney Donation by Psoriasis Patients: Potential Challenges and Approach From a Dermatologist's Perspective	5
Criteria for immediate extubation after pediatric liver transplantation in a single pediatric liver transplant center in Japan	5
COVID‐19‐associated acute cellular rejection of a transplanted heart	5
The impact of pre‐existing hematologic disorders on morbidity and mortality following heart transplantation: Focus on early graft dysfunction	5
Donor Atheromatous Disease is a Risk Factor for Hepatic Artery Thrombosis After Liver Transplantation	5
Correction to “Donor's long‐term quality of life following living‐donor lobar lung transplantation”	5
Serologic follow‐up of solid organ transplant recipients who received organs from donors with reactive syphilis tests: A retrospective cohort study	5